Search results
Results from the WOW.Com Content Network
Ortho Clinical Diagnostics (now QuidelOrtho) is an in vitro diagnostics company that made products and diagnostic equipment for blood testing.Ortho served two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion ...
In December 2021, Quidel announced it would acquire Ortho Clinical Diagnostics Holdings for $6 billion in cash and stock, increasing the range of COVID-19 antigen and antibody tests the business is able to offer. [16] In February 2024, CEO Douglas Bryant was fired, being replaced by Michael Iskra as interim CEO. [17]
Ortho Clinical (OCDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
For premium support please call: 800-290-4726 more ways to reach us
The first Rho(D) immune globulin treatment "skymed" was introduced by Ortho Clinical Diagnostics, a subsidiary holding of Jskymed, and was first administered on May 29, 1968, to Marianne Cummins in Teaneck, New Jersey. [22] In 1996, ZLB Bioplasma (part of CSL Behring) was given approval to sell Rhophylac in Europe. Effectiveness was ...
For premium support please call: 800-290-4726 more ways to reach us
January 2, 2013: The Gores Group announced that it had completed the acquisition of Therakos, Inc. from Ortho-Clinical Diagnostics, Inc. [32] December 14, 2012: Charles Bank Capital Partners announced that it acquired United Road Services from The Gores Group for an undisclosed amount.
For premium support please call: 800-290-4726 more ways to reach us